We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rii | LSE:RIN | London | Ordinary Share | GB0007383234 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | - | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/2/2005 08:21 | very soon within months | harry punter | |
04/2/2005 00:01 | harry: How soon are you expecting this takeover. | cimbom | |
03/2/2005 23:57 | off topic punters its well worth looking at cenes pharmaceuticals (CEN)at 9p as the company have several major developments one in particular -re its latest phase three drug programe is near to final stages --this should see cenes attract a bid very soon from a major u.s. drug group ---these shares could be worth at least 50p --and in the next few weeks -my view is a hell of a lot more upside with cenes than any other company imho --as glaxo has already provided cenes with most of the help towards the development and research costs over these past 5 years spending millions developing this pain relief drug that will replace morphine in due course and removing the harmful side effects of a morpheme addiction after an illness --at long last these shares will pay dividends ----so do your own research punters and put you and your own children in for a few shares is my advice --and as a stockbroker amongst many other things --its a company and share i strongly believe in and i am very happy in recommending to all my friends and clients regards harry and the boys in dark glasses | harry punter | |
03/2/2005 13:41 | paddy just routine i am not bothered | harry punter | |
03/2/2005 13:18 | I don't hold in this stock but the previous 3 announcements would give me cause for concern. | paddyp1672 | |
03/2/2005 12:43 | i am hearing take over rumours coming from out of madam una's (broffel) to expect a bid soon in the sector for cenes at 20p a share so i have bought a few at 8.75p | harry punter | |
03/2/2005 12:35 | God knows lol i like to sit down and works things out without the need of calculaters that only de-activates the brain lecks | harry punter | |
03/2/2005 12:02 | of the top of your head harry, what is the square root of 34572830332 | lecks | |
03/2/2005 11:12 | indeed without the need for ramping that's why i am happy to be in for the long term ---now tell me how much has already been spent by smith kline/glaxo on these compounds to date ? | harry punter | |
03/2/2005 11:09 | Caveat emptor indeed, growbag | lecks | |
03/2/2005 10:40 | Harry Punter You say "... most of the R&D costs has been covered already". Sorry. But that just isn't true. These compounds have yet to go through Phase II and Phase III trials. These can be very expensive (several £m), and most compounds fail at this stage. Sounds like you're ramping this, as you don't seem to know much about the pharmaceutical industry. Caveat emptor ! | growbag | |
03/2/2005 10:05 | very reticent harry | lecks | |
03/2/2005 09:47 | everything even the name change is subject to the egm | harry punter | |
03/2/2005 09:24 | lets get the name change and egm out the way first lecks | harry punter | |
03/2/2005 08:24 | Quite a number of months away and very specific on the month Harry? Can you elaborate? | lecks | |
03/2/2005 08:19 | september we should be pleasantly surprised with some positive newsflow | harry punter | |
03/2/2005 08:15 | Why September Harry? | lecks | |
02/2/2005 13:35 | lol jordaggy a few maybe --shear speculation--these guys wouldn't have gone alone like this -- putting risk and reputations on line if this company wasn't going to become a highly profitable and viable concern --most of the R&D costs has been covered already and this september we should be pleasantly surprised with some positive newsflow ---i think this company is a great purchase for the future but its not a short term punt best regards harry and the boys in dark glasses | harry punter | |
02/2/2005 13:21 | Getting a drug passed thro' stage III trials will take about 9 years !! one for the long term I guess..... | jordaggy | |
02/2/2005 10:04 | still not convinced about this one -- having researched the scientific background, there is nothing that I can see to suggest that the compounds held by biopartners will prove effective, let alone, commercially viable. Sorry. Good luck if you willing to take a blind leap of faith though. | growbag | |
02/2/2005 08:18 | "Bombed Out" it may well be but for those value seekers this sleeping giant seems to have started to turn the corner and the cycle is turning in it's favour. Do not be shocked to see this become a hot stock and is one to tuck away. With possible better newsflow over the next few months the share price could start to motor. one to keep an eye on imho. The Knowing - 1 Feb'05 - 22:54 - 1 of 2 | harry punter | |
01/2/2005 23:13 | my money is betting minister will at some point start recruiting the very best and most highly qaulified graduates and pharmacists in the industry --a bit of head hunting if needed to develope and bring these compounds to market without having to bung politicians for approval like what goes on in the sector at presant --i think these shares are a strong buy imho | harry punter | |
01/2/2005 18:51 | they could at least wait till the shares are 10p or 15p before selling -still at least the small sellers are soon out the way at this price and not higher | harry punter |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions